RG
Redmile Group’s Cytosorbents Corp CTSO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-181,639
| Closed | -$612K | – | 76 |
|
|
2023
Q1 | $612K | Sell |
181,639
-84,726
| -32% | -$286K | 0.03% | 74 |
|
|
2022
Q4 | $413K | Hold |
266,365
| – | – | 0.02% | 68 |
|
|
2022
Q3 | $362K | Hold |
266,365
| – | – | 0.01% | 70 |
|
|
2022
Q2 | $583K | Hold |
266,365
| – | – | 0.02% | 70 |
|
|
2022
Q1 | $850K | Sell |
266,365
-450,879
| -63% | -$1.44M | 0.03% | 69 |
|
|
2021
Q4 | $3.01M | Sell |
717,244
-327,190
| -31% | -$1.37M | 0.07% | 67 |
|
|
2021
Q3 | $8.48M | Sell |
1,044,434
-259,935
| -20% | -$2.11M | 0.15% | 65 |
|
|
2021
Q2 | $9.85M | Sell |
1,304,369
-823,262
| -39% | -$6.22M | 0.15% | 75 |
|
|
2021
Q1 | $18.5M | Buy |
2,127,631
+73,500
| +4% | +$638K | 0.26% | 70 |
|
|
2020
Q4 | $16.4M | Sell |
2,054,131
-47,000
| -2% | -$375K | 0.2% | 67 |
|
|
2020
Q3 | $16.8M | Buy |
+2,101,131
| New | +$16.8M | 0.31% | 58 |
|